Thromboxane A 2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism

Cell Death and Differentiation

Volumn 19, Issue 8, 2012, Pages 1347-1357

  Iorio Morin, C ^a,b,c   Germain, P ^a,b,c   Roy, S ^a,b,c   Genier S ^a,b,c   Labrecque, P ^a,b,c   Parent, J L ^a,b,c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

apoptosis; cancer; cisplatin; G protein coupled receptor; Siva; thromboxane

Indexed keywords

AMINO ACID; AMINO ACID SIVA1; CISPLATIN; PROTEIN MDM2; SMALL INTERFERING RNA; THROMBOXANE A2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; APOPTOSIS REGULATORY PROTEIN; CYCLOHEXIMIDE; SIVA1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; BIOSYNTHESIS; CELL STRAIN HEK293; CONFOCAL MICROSCOPY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HELA CELL; METABOLISM; PHYSIOLOGY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CISPLATIN; CYCLOHEXIMIDE; HEK293 CELLS; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; THROMBOXANE A2; TRANSFECTION;

EID: 84863719328     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.11     Document Type: Article

References (38)

1. Nakahata N. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 2008; 118: 18-35.
2. Parent JL, Labrecque P, Orsini MJ, Benovic JL. Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced cooh terminus in agonist-promoted receptor internalization. J Biol Chem 1999; 274: 8941-8948. (Pubitemid 29164696)
3. Parent A, Laroche G, Hamelin E, Parent J-L. RACK1 regulates the cell surface expression of the G protein-coupled receptor for thromboxane A(2). Traffic 2008; 9: 394-407. (Pubitemid 351188998)
4. Py B, Slomianny C, Auberger P, Petit PX, Benichou S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol 2004; 172: 4008-4017. (Pubitemid 38375212)
5. Singaravelu K, Padanilam BJ. p53 target Siva regulates apoptosis in ischemic kidneys. Am J Physiol Renal Physiol 2011; 300: F1130-F1141.
6. Padanilam BJ, Lewington AJ, Hammerman MR. Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int 1998; 54: 1967-1975. (Pubitemid 28533624)
7. Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS et al. The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis. J Carcinog 2009; 8: 2.
8. Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM et al. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem 2004; 279: 28706-28714. (Pubitemid 38900155)
9. Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S et al. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis 2004; 9: 83-95. (Pubitemid 38270432)
10. Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R. Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J Cell Sci 2009; 122 (Pt 15): 2651-2661.
11. Du W, Jiang P, Li N, Mei Y, Wang X, Wen L et al. Suppression of p53 activity by Siva1. Cell Death Differ 2009; 16: 1493-1504.
12. Spinicelli S, Nocentini G, Ronchetti S, Krausz LT, Bianchini R, Riccardi C. GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ 2002; 9: 1382-1384. (Pubitemid 36097709)
13. E S, Lai Y-J, Tsukahara R, Chen C-S, Fujiwara Y, Yue J et al. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. J Biol Chem 2009; 284: 14558-14571.
14. Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S et al. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 1997; 94: 6346-6351.
15. Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, Honn KV. The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer Metastasis Rev 2011; 30: 397-408.
16. Lin KH, Chang HC, Lu WJ, Jayakumar T, Chou HC, Fong TH et al. Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents. Platelets 2009; 20: 575-581.
17. Shizukuda Y, Buttrick PM. Protein kinase C-zeta modulates thromboxane A(2)-mediated apoptosis in adult ventricular myocytes via Akt. Am J Physiol Heart Circ Physiol 2002; 282: H320-H327. (Pubitemid 34654164)
18. Remuzzi G, Noris M, Benigni A, Imberti O, Sayegh MH, Perico N. Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides. J Exp Med 1994; 180: 1967-1972.
19. Liel N, Mais DE, Halushka PV. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Prostaglandins 1987; 33: 789-797.
20. Severino A, Abbruzzese C, Manente L, Valderas Á A, Mattarocci S, Federico A et al. Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes. J Cell Physiol 2007; 212: 118-125. (Pubitemid 46867593)
21. Gudi R, Barkinge J, Hawkins S, Prabhakar B, Kanteti P. Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB. J Environ Pathol Toxicol Oncol 2009; 28: 25-38.
22. Brown DR, Thomas CA, Deb SP. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J 1998; 17: 2513-2525. (Pubitemid 28221187)
23. Vischioni B, van der Valk P, Span SW, Kruyt FAE, Rodriguez JA, Giaccone G. Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol 2006; 37: 78-86. (Pubitemid 41790506)
24. Lin Y, Ryan J, Lewis J, Wani MA, Lingrel JB, Liu Z-G. TRAF2 exerts its antiapoptotic effect by regulating the expression of Krü ppel-like factor LKLF. Mol Cell Biol 2003; 23: 5849-5856. (Pubitemid 36951346)
25. Moussa O, Riker JM, Klein J, Fraig M, Halushka PV, Watson DK. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene 2008; 27: 55-62.
26. Huang R-Y, Li M-Y, Hsin MKY, Underwood MJ, Ma LT, Mok TSK et al. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor. Oncogene 2011; 30: 106-116.
27. Yoshizato K, Zapf S, Westphal M, Berens ME, Giese A. Thromboxane synthase inhibitors induce apoptosis in migration-arrested glioma cells. Neurosurgery 2002; 50: 343-354. (Pubitemid 41672590)
28. Datar S, McCauley FA, Wilson TW. Testing the 'redirection hypothesis' of prostaglandin metabolism in the kidney. Prostaglandins 1987; 33: 275-285. (Pubitemid 17055295)
29. Hatae T, Wada M, Yokoyama C, Shimonishi M, Tanabe T. Prostacyclin- dependent apoptosis mediated by PPAR delta. J Biol Chem 2001; 276: 46260-46267.
30. Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem 2008; 104: 1124-1149. (Pubitemid 351961689)
31. Blöchl-Daum B, Pehamberger H, Kurz C, Kyrle PA, Wagner O, Mü ller M et al. Effects of cisplatin on urinary thromboxane B2 excretion. Clin Pharmacol Ther 1995; 58: 418-424.
32. Papanikolaou N, Peros G, Morphake P, Gkikas G, Maraghianne D, Tsipas G et al. Does gentamicin induce acute renal failure by increasing renal TXA2 synthesis in rats? Prostaglandins Leukot. Essent Fatty Acids 1992; 45: 131-136.
33. Rossini M, Belloni A, Remuzzi G, Perico N. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. Circulation 1990; 81 (1 Suppl): I61-I67 discussion I68.
34. Lin F-T, Lai Y-J, Makarova N, Tigyi G, Lin W-C. The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J Biol Chem 2007; 282: 37759-37769.
35. Czembirek C, Eder-Czembirek C, Erovic BM, Turhani D, Selzer E, Thurnher D. Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines. Oncol Rep 2005; 14: 1523-1526.
36. Togna GI, Togna AR, Franconi M, Caprino L. Cisplatin triggers platelet activation. Thromb Res 2000; 99: 503-509.
37. Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, Riabowol K. REAP: a two minute cell fractionation method. BMC Res Notes 2010; 3: 294.
38. Gassmann M, Grenacher B, Rohde B, Vogel J. Quantifying Western blots: pitfalls of densitometry. Electrophoresis 2009; 30: 1845-1855.